TNSN98087A1 - Composition pharmaceutique en aerosol - Google Patents

Composition pharmaceutique en aerosol

Info

Publication number
TNSN98087A1
TNSN98087A1 TNTNSN98087A TNSN98087A TNSN98087A1 TN SN98087 A1 TNSN98087 A1 TN SN98087A1 TN TNSN98087 A TNTNSN98087 A TN TNSN98087A TN SN98087 A TNSN98087 A TN SN98087A TN SN98087 A1 TNSN98087 A1 TN SN98087A1
Authority
TN
Tunisia
Prior art keywords
aerosol
inhaler
aerosol particles
pharmaceutical composition
low volatility
Prior art date
Application number
TNTNSN98087A
Other languages
English (en)
French (fr)
Inventor
Gaetano Brambilla
Raffaella Garzia
Brian Meakin
David Lewis
Davis Ganderton
Paolo Ventura
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TNSN98087(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of TNSN98087A1 publication Critical patent/TNSN98087A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TNTNSN98087A 1997-06-13 1998-06-12 Composition pharmaceutique en aerosol TNSN98087A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions

Publications (1)

Publication Number Publication Date
TNSN98087A1 true TNSN98087A1 (fr) 2005-03-15

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN98087A TNSN98087A1 (fr) 1997-06-13 1998-06-12 Composition pharmaceutique en aerosol

Country Status (44)

Country Link
EP (2) EP1219293A3 (forum.php)
JP (1) JP4380802B2 (forum.php)
KR (1) KR100546239B1 (forum.php)
CN (1) CN1138532C (forum.php)
AR (1) AR012977A1 (forum.php)
AT (1) ATE222751T1 (forum.php)
AU (1) AU729966B2 (forum.php)
BG (1) BG63906B1 (forum.php)
BR (1) BR9805993B1 (forum.php)
CA (1) CA2263445C (forum.php)
CO (1) CO4940408A1 (forum.php)
CZ (1) CZ295521B6 (forum.php)
DE (1) DE69807420T3 (forum.php)
DK (1) DK0920302T4 (forum.php)
DZ (1) DZ2516A1 (forum.php)
EA (1) EA001259B1 (forum.php)
EE (1) EE03664B1 (forum.php)
ES (1) ES2182351T5 (forum.php)
GB (1) GB2326334A (forum.php)
GE (1) GEP20012462B (forum.php)
HR (1) HRP980317B1 (forum.php)
HU (1) HU228487B1 (forum.php)
ID (1) ID21491A (forum.php)
IL (1) IL128484A (forum.php)
IN (1) IN189317B (forum.php)
IS (1) IS2435B (forum.php)
IT (1) IT1293803B1 (forum.php)
MA (1) MA26507A1 (forum.php)
ME (2) MEP44008A (forum.php)
MY (1) MY119074A (forum.php)
NO (1) NO327775B1 (forum.php)
NZ (1) NZ334149A (forum.php)
PL (1) PL193721B1 (forum.php)
PT (1) PT920302E (forum.php)
RS (1) RS51274B (forum.php)
SA (1) SA98190821B1 (forum.php)
SI (1) SI0920302T2 (forum.php)
SK (1) SK284430B6 (forum.php)
TN (1) TNSN98087A1 (forum.php)
TR (1) TR199900288T1 (forum.php)
TW (1) TW555570B (forum.php)
UA (1) UA70289C2 (forum.php)
WO (1) WO1998056349A1 (forum.php)
ZA (1) ZA985136B (forum.php)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
CA2317999C (en) 1999-09-11 2004-11-09 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
EP1523976A3 (en) * 1999-11-23 2005-06-22 Glaxo Group Limited Pharmaceutical formulations of salmeterol
AU2206801A (en) * 1999-12-24 2001-07-09 Alan Leslie Cripps Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
HRP20021025B1 (hr) * 2000-05-22 2013-11-22 Chiesi Farmaceutici S.P.A. Formulacije stabilnih farmaceutskih otopina za inhalatore s odmjerenom dozom pod tlakom
AU2002238748A1 (en) * 2001-03-12 2002-09-24 Glaxo Group Limited Pharmaceutical aerosol formulation
TR200401980T4 (tr) 2001-07-02 2004-09-21 Chiesi Farmaceutici S.P.A. Aerosol olarak uygulama için en uygun hale getirilmiş tobramisin formülasyonu
ATE465712T1 (de) 2002-03-01 2010-05-15 Chiesi Farma Spa Ultrafeine zusammensetzungen von formoterol
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
ES2275778T3 (es) * 2002-06-06 2007-06-16 Chiesi Farmaceutici S.P.A. Solubilizacion de farmacos en propulsores de hfa mediante emulsiones.
EP1599184A4 (en) * 2003-02-04 2009-06-24 Chrysalis Tech Inc FULLY HALOGENATED FLUOROCARBON HYDROGEN AND HYDROFLUOROCHLOROUS HYDROGEN FUELS AND METHOD FOR THE PRODUCTION AND USE THEREOF
ME00420B (me) * 2003-03-20 2011-12-20 Boehringer Ingelheim Pharmaceuticals Inc Formulacija, za inhalator u kojem se odmjerava doza, u kojoj se kao propelenti koriste hidro-fluoro-alkani
EP1915985A1 (en) * 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
PL1809243T5 (pl) 2004-07-02 2022-12-27 Boehringer Ingelheim International Gmbh Preparaty aerozolowe w postaci zawiesin z tg 227 ea jako propelent aerozolowy
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
US20110105449A1 (en) * 2007-11-07 2011-05-05 Astrazeneca R&D Dry powder formulations comprising ascorbic acid derivates
BR112013005284A2 (pt) * 2010-09-06 2019-09-24 Chiesi Farm Spa inalador dosimetrado e uso de um inalador dosimetrado
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
WO2013127738A1 (de) 2012-02-28 2013-09-06 Boehringer Ingelheim International Gmbh Neue treibgashaltige tiotropium-formulierung
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
EP3174522A1 (en) 2014-07-29 2017-06-07 3M Innovative Properties Company Method of preparing a pharmaceutical composition
MA43782A (fr) 2016-03-31 2021-04-28 Chiesi Farm Spa Dispositif d'inhalation d'aérosol
AU2017328908B2 (en) * 2016-09-19 2020-04-02 Mexichem Fluor S.A. De C.V. Pharmaceutical composition
WO2025039045A1 (en) * 2023-08-23 2025-02-27 Inhaler Supplies Pty Ltd Inhalable formulation for volatile actives

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU601176B2 (en) † 1986-03-10 1990-09-06 Kurt Burghart Benzodiazepine aerosols
WO1987005211A1 (en) † 1986-03-10 1987-09-11 Kurt Burghart Pharmaceutical preparation and process for producing the same
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
WO1992006675A1 (en) † 1990-10-18 1992-04-30 Minnesota Mining And Manufacturing Company Aerosol formulation comprising beclomethasone 17,21 dipropionate
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
EP1092430B1 (en) † 1991-06-10 2003-08-06 Schering Corporation Non-chlorofluorocarbon aerosol formulations
IL102130A0 (en) † 1991-06-10 1993-01-14 Schering Corp Non-chlorofluorocarbon aerosol formulations
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
WO1993011745A1 (en) * 1991-12-12 1993-06-24 Glaxo Group Limited Medicaments
PT1086688E (pt) * 1991-12-18 2004-06-30 Minnesota Mining & Mfg Formulacoes de aerossol em suspensao
DE69324161T2 (de) * 1992-12-09 1999-10-28 Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield Stabilisierte medizinische aerosollösungen
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
CA2189351C (en) † 1994-05-13 2008-12-30 Stephen J. Farr Narcotic containing aerosol formulation
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
JP2000514085A (ja) * 1996-07-08 2000-10-24 ローヌ―プーラン・ロウラー・リミテッド 医薬シクロスポリンａエーロゾル溶液処方物
WO1998024420A1 (en) † 1996-12-04 1998-06-11 Bioglan Ireland (R & D) Limited Pharmaceutical compositions and devices for their administration
ES2178817T3 (es) † 1997-02-05 2003-01-01 Jago Res Ag Formulaciones medicinales de aerosol.

Also Published As

Publication number Publication date
DZ2516A1 (fr) 2004-11-08
SA98190821B1 (ar) 2006-11-19
CN1229355A (zh) 1999-09-22
EE9900055A (et) 1999-08-16
CA2263445C (en) 2008-09-09
WO1998056349A1 (en) 1998-12-17
EP0920302B1 (en) 2002-08-28
AU729966B2 (en) 2001-02-15
SK17699A3 (en) 1999-07-12
ES2182351T3 (es) 2003-03-01
IN189317B (forum.php) 2003-02-08
BR9805993A (pt) 1999-08-31
CN1138532C (zh) 2004-02-18
HRP980317B1 (en) 2002-06-30
TR199900288T1 (xx) 1999-09-21
PT920302E (pt) 2002-11-29
EP1219293A2 (en) 2002-07-03
GB9712434D0 (en) 1997-08-13
DE69807420T3 (de) 2006-11-16
NO990594D0 (no) 1999-02-09
DE69807420D1 (de) 2002-10-02
CO4940408A1 (es) 2000-07-24
UA70289C2 (uk) 2004-10-15
HK1022271A1 (en) 2000-08-04
HUP0001339A3 (en) 2000-10-30
IL128484A (en) 2004-09-27
CA2263445A1 (en) 1998-12-17
NO327775B1 (no) 2009-09-21
GB2326334A (en) 1998-12-23
HRP980317A2 (en) 1999-04-30
HU228487B1 (en) 2013-03-28
NZ334149A (en) 2000-07-28
ITMI971798A1 (it) 1999-01-28
HUP0001339A2 (hu) 2000-09-28
SI0920302T2 (sl) 2006-10-31
ID21491A (id) 1999-06-17
IS4974A (is) 1999-02-11
SK284430B6 (sk) 2005-04-01
EP1219293A3 (en) 2003-05-28
MA26507A1 (fr) 2004-12-20
SI0920302T1 (en) 2002-12-31
ATE222751T1 (de) 2002-09-15
BG63906B1 (bg) 2003-06-30
IT1293803B1 (it) 1999-03-10
CZ46299A3 (cs) 1999-07-14
ME00333B (me) 2011-02-10
IL128484A0 (en) 2000-01-31
EP0920302A1 (en) 1999-06-09
PL331531A1 (en) 1999-07-19
AU8626298A (en) 1998-12-30
ZA985136B (en) 1999-01-07
TW555570B (en) 2003-10-01
YU6999A (sh) 2000-03-21
IS2435B (is) 2008-10-15
ES2182351T5 (es) 2007-03-16
EA199900201A1 (ru) 1999-06-24
RS51274B (sr) 2010-12-31
MY119074A (en) 2005-03-31
BG103221A (en) 1999-09-30
EP0920302B2 (en) 2006-06-21
KR100546239B1 (ko) 2006-01-26
JP2000516965A (ja) 2000-12-19
DK0920302T4 (da) 2006-10-09
KR20000068171A (ko) 2000-11-25
MEP44008A (en) 2011-02-10
JP4380802B2 (ja) 2009-12-09
PL193721B1 (pl) 2007-03-30
DK0920302T3 (da) 2002-12-23
EE03664B1 (et) 2002-04-15
NO990594L (no) 1999-04-13
DE69807420T2 (de) 2003-05-08
EA001259B1 (ru) 2000-12-25
GEP20012462B (en) 2001-06-25
BR9805993B1 (pt) 2009-05-05
AR012977A1 (es) 2000-11-22
CZ295521B6 (cs) 2005-08-17

Similar Documents

Publication Publication Date Title
TNSN98087A1 (fr) Composition pharmaceutique en aerosol
TNSN01074A1 (fr) Formulations pharmaceutiques stables en solution pour inhalateurs sous pression a comptage de dose
Gowen et al. Stimulation of bone resorption in vitro by a non-prostanoid factor released by human monocytes in culture
Kennedy Jr Dermal toxicity of ammonium perfluorooctanoate
CA2067754A1 (en) Preparation for the application of agents in mini-droplets
BE901994A (fr) Comprimes de principes actifs pharmaceutiques a delitement rapide, stables au stockage.
FR2730637B1 (fr) Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
PT814793E (pt) Preparacoes de aerossol de prilocaina e hidrofluorocarboneto
JP2002536315A5 (forum.php)
WO2002043750A3 (en) Method for the stabilizing of biomolecules (e.g. insulin) in liquid formulations
EA200101266A1 (ru) Новый препарат и форма для введения, включающие неустойчивое в кислой среде действующее вещество
BR0013919A (pt) Suspensão estável concentrada de pesticida
GR3030528T3 (en) Viscoelastic compositions of fluorinated organic compounds
BR0007201A (pt) Composições incluindo agentes de preservação demalto-oligossacarìdeos reduzidos, e métodospara preservar um material
EP0904837A3 (en) Hydrosilylation catalyst and hydrosilylation method
TR200200841T2 (tr) Mukozaya uygulama için, siklesonid içeren farmasötik kompozisyon
WO2002011538A3 (en) Floating type formulation of agricultural agents
KR970701535A (ko) 비타민 E를 함유하는 에어로졸 약물 제형(Aerosol drug formulations containing vitamin'E)
JPS5653608A (en) Emulsified stick cosmetic
FR2406998A1 (fr) Batonnet deodorant contenant un bicarbonate
Benedeczky et al. ELECTRONMICROSCOPIC ANALYSIS OF THE CYTOPATHOLOGICAI. EFFECT OF PESTICIDES IN THF. LIVER, KIDNEY AND GILL TISSUES OF CARP
ES8100852A1 (es) Un metodo para la conservacion de plantas vivas
JPS5572110A (en) Transfusion fluid for oxygen transfer
ATE207437T1 (de) Auflösungssystem für eine wirkstoffhaltige flüssige lösung
Sahilli THE ROLE OF GLUTATHIONE IN THE DETOXIFICA-TION OF PERCHLOROETHYLENE